CMS Device Coverage

When research at Memorial Hermann Healthcare System(MHHS) involves devices, please contact MHHS - Clinical Innovation and Research InstituteSusmitha Gadde, Director of Research Operations at  or  713-704-3430 as soon as possible.

  • MHHS will start the process to check if the vendor is approved, if not they'll start the process for vendor approval.  Simultaneously a determination of whether a Hospital Site Agreement/ Facility Use Agreement is required will be made. Please provide the hospital with sponsor/CRO contact information to expedite the vendor vetting process. 
  • MHH staff will also determine if an NCD is required.  MHH staff will also determine if local Medicare Administrative Contractor's(MAC) - Novitas Solutions, coverage determination is required. Please provide unredacted FDA approval letter for review.
  • If approval from CMS is required, MHH staff will guide the coordinator to submit to Novitas for approval.


For Category A Devices – Provider or coordinator will submit the following: 

  • Notify their CMS contractor that a Category A IDE device is a part of the qualified clinical trial before routine costs of that clinical trial can be billed. 
  • After the contractor receives information about the clinical trial, the contractor will then determine if the Category A IDE that is used in the trial is used to diagnose, monitor, or treat any immediately life-threatening disease or condition. 
  • If the contractor determines that the device does meet these requirements then the provider may begin billing the routine costs of the clinical trial.


 For Category B Devices -  The provider who is participating in the study of the IDE Category B device must submit the following information about the device, the study, the participating Medicare beneficiaries, and the site where the study will be conducted prior to its use:

  • A copy of the most recent un-redacted/unconditional FDA-approved letter sent to the sponsor or manufacturer of the device.  The IDE number must be included in the letter
  • Verification of Institutional Review Board approval
  • Name of the device (both trade, common or usual, and classification name)
  • Any action taken to conform to any applicable IDE special controls (Study specific, depends on device classification and protocol design. Sponsor should be able to provide this information).
  • A narrative description of the device that tells how the device is similar or different from other comparable devices
  • Indication if the device will be billed in an outpatient or inpatient setting
  • A brief summary of the study design or a copy of the actual study protocol
  • The provider's protocol for obtaining informed consents from the beneficiaries that are participating in the trial.
  • The provider's NPI number.


All documentation must be sent to:

Office of the Contractor Medical Director

Novitas Solutions

1800Center Street Camp Hill, PA 17089-0089

Attention: JH IDE Applications


Email inquiries regarding IDE requests can be sent to:

Phone: 469-372-0992

Fax: 469-312-2649

For more information -



Debra Patterson, MD

Charles Haley, MD



Center for Clinical and Translational Sciences

Clinical Trials Resource Center (CTRC)
7000 Fannin Street, Suite 795

Houston, Texas 77030
phone 713-500-3622
fax 713-500-0334

last modified October, 2013
Copyright © 2012
How can we improve this site?